发明授权
- 专利标题： FDG-pet evaluation of Ewing's sarcoma sensitivity
- 专利标题（中）： FDG宠物评估尤文肉瘤敏感性
-
申请号： US12879359申请日： 2010-09-10
-
公开(公告)号： US08470297B1公开(公告)日： 2013-06-25
- 发明人: Brian DerHua Lu , Siu-Long Yao , Cynthia Seidel-Dugan , Yan Wang
- 申请人： Brian DerHua Lu , Siu-Long Yao , Cynthia Seidel-Dugan , Yan Wang
- 申请人地址： US NJ Rahway
- 专利权人： Merck Sharp & Dohme Corp.
- 当前专利权人： Merck Sharp & Dohme Corp.
- 当前专利权人地址： US NJ Rahway
- 主分类号： A61K51/00
- IPC分类号： A61K51/00 ; A61M36/14
摘要：
This invention relates to methods for evaluating the efficacy of an IGF1R inhibitor, such as an anti-IGF1R antibody, for the treatment of an Ewing's sarcoma tumor by determining the level of tumoral glucose metabolism. Tumoral glucose metabolism is determining at an early point in the treatment regimen by any of several methods known in the art including FDG-PET/CT scan.
信息查询
